Roth Capital Partners analyst Boobalan Pachaiyappan lowered his target on Gain Therapeutics (Gain Therapeutics Stock Quote, Chart, News, Analysts, Financials NASDAQ:GANX) to US$5.00 from $8.00, saying the company’s experimental Parkinson’s disease treatment has shown encouraging signs of stabilizing motor function, but its effectiveness still needs to be demonstrated in a controlled clinical trial. On Nov. […]

Source

WELLSTAR Technologies’ (WELLSTAR Technologies Corp. Stock Quote, Chart, News, Analysts, Financials TSXV:WSTR) first quarterly results as a public company exceeded revenue and earnings expectations, strengthening Haywood Securities analyst Gianluca Tucci’s outlook for the Canadian healthcare technology provider. Tucci maintained his “Buy” rating and $10.25 target on Nov. 11, offering that the company’s recurring revenue, expanding […]

Source

Volatus Aerospace’s (Volatus Aerospace Stock Quote, Chart, News, Analysts, Financials TSX:FLT) first Canadian Armed Forces contract and growing defence order book have strengthened its growth prospects, although higher spending and lower margins continue to delay profitability, according to Haywood Securities analyst Gianluca Tucci. In his Nov. 11 report, Tucci maintained his “Buy” rating and $0.90 […]

Source

Regina-based VC re-opened the fund earlier this year after increased demand from investors.

The post Conexus Venture Capital raises additional $5 million for Fund II first appeared on BetaKit.

WELL Health Technologies’ (WELL Health Technologies Stock Quote, Chart, News, Analysts, Financials TSX:WELL) Canadian clinic operations delivered strong third-quarter growth, while the potential sale of its U.S. businesses could provide the next opportunity to increase shareholder value, according to Haywood Securities analyst Gianluca Tucci. On Nov. 10, Tucci maintained his “Buy” rating and $8.00 target […]

Source

Supported by YSpace’s ELLA program, the EdTech startup is using AI to make oral exams practical for universities.

The post Coraltalk wants universities to stop chasing AI cheaters and start measuring learning first appeared on BetaKit.

Quarterhill (Quarterhill  Stock Quote, Chart, News, Analysts, Financials TSX:QTRH) remains on track to complete its acquisition of Conduent’s tolling business in the fourth quarter, a transaction that could more than double the Toronto-based transportation technology company’s annual revenue. Beacon Securities analyst Gabriel Leung maintained his “Buy” rating and C$5.50 target following Quarterhill’s third-quarter results, writing […]

Source

Medicenna Therapeutics’ (Medicenna Therapeutics Stock Quote, Chart, News, Analysts, Financials TSX:MDNA) experimental cancer treatment MDNA11 produced encouraging responses in patients with gastrointestinal cancers that had stopped responding to existing immunotherapies, potentially strengthening the company’s prospects for a pharmaceutical partnership. Research Capital Corporation analyst Andre Uddin maintained his “Speculative Buy” rating and C$1.60 target on the […]

Source

Former LeddarTech CEO’s new venture targets autonomous vehicle and robotics companies. 

The post Qvyon Technologies emerges from stealth with $8 million USD to prepare physical AI for dangerous edge cases  first appeared on BetaKit.

Nearly 10 years in, Ottawa company eyes surge in demand from AI infrastructure build-out.

The post BluWave-ai secures $8.1 million for energy grid software as data centres strain load first appeared on BetaKit.

The Toronto VC has closed $17 million to date to back Canadian tech startups at inception.

The post Northside Ventures aims to build “institutional angel investor” with $30-million USD second fund first appeared on BetaKit.

The Ministry of Natural Resources and Forestry says strong predation numbers of wolves and black bears could be a major factor in moose decline while a conservationist says rising temperatures are putting stress on the large mammals.

CBC News has learned that several Halifax-area hospitals have been dealing with soaring costs to deal with mice and pigeon infestations. Nova Scotia Health says it could take years to rid its facilities of the mice issue.

Plus: Nvidia’s governance problem.

The post Jack Newton’s tips for a $1 billion acquisition first appeared on BetaKit.

Calgary-based company is considering several options, but says intention is to keep footprint in Canada.

The post Summit Lithium Technologies exploring M&A deal, possibly to foreign buyer first appeared on BetaKit.

Village Farms International’s (Village Farms International Stock Quote, Chart, News, Analysts, Financials NASDAQ:VFF) stronger-than-expected third-quarter results and plans to expand cannabis production in British Columbia could substantially increase earnings, according to Beacon Securities analyst Doug Cooper. In a Nov. 9 report, Cooper maintained his “Buy” rating and US$8.00 target, arguing that the company’s existing production […]

Source

EVgo’s (EVgo Stock Quote, Chart, News, Analysts, Financials NYSE:EVGO) largest shareholder has proposed taking the electric vehicle charging company private for US$2.00 per share, a development that has led Roth Capital Partners analyst Craig Irwin to downgrade the stock to “Neutral” from “Buy.” In a Nov. 9 report, Irwin maintained his US$2.00 target, arguing that […]

Source

US AI safety researcher Paul Christiano says progress will accelerate thanks to AI itself.

The post AI development unlikely to slow anytime soon, OpenAI Foundation board member says first appeared on BetaKit.

ATB Cormark Capital Markets analyst Gavin Fairweather has assumed coverage of Kinaxis (Kinaxis Stock Quote, Chart, News, Analysts, Financials TSX:KSX) with an “Outperform” rating and C$250.00 target, arguing that accelerating software sales, improving customer retention and new artificial intelligence products could support stronger growth and profitability. In a Nov. 10 report, Fairweather said the Ottawa-based […]

Source

Small cap stocks have shown some life since large-cap tech stocks stumbled in October. In a November 10 Motley Fool article published by Yahoo Finance, David Dierking argues that the rebound could have further to run. He points to expectations for faster earnings growth, reasonable valuations and less exposure to questions about how much big […]

Source